Mariner

Mariner Portfolio holdings

AUM $77.4B
1-Year Est. Return 22.02%
This Quarter Est. Return
1 Year Est. Return
+22.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$69.3B
AUM Growth
+$9.18B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,740
New
Increased
Reduced
Closed

Top Buys

1 +$265M
2 +$194M
3 +$181M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$116M
5
JPM icon
JPMorgan Chase
JPM
+$103M

Top Sells

1 +$87M
2 +$76.3M
3 +$39.7M
4
TGT icon
Target
TGT
+$28.4M
5
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$24M

Sector Composition

1 Technology 20.79%
2 Financials 8.13%
3 Consumer Discretionary 5.23%
4 Healthcare 4.75%
5 Communication Services 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAP icon
3601
Advance Auto Parts
AAP
$2.59B
-6,813
ABCL icon
3602
AbCellera Biologics
ABCL
$1.23B
-10,966
ABM icon
3603
ABM Industries
ABM
$2.72B
-4,447
ACAD icon
3604
Acadia Pharmaceuticals
ACAD
$4.4B
-18,190
ACI icon
3605
Albertsons Companies
ACI
$8.9B
-30,107
ACIO icon
3606
Aptus Collared Investment Opportunity ETF
ACIO
$2.24B
-7,888
ACRE
3607
Ares Commercial Real Estate
ACRE
$281M
-12,558
ACTV
3608
DELISTED
LeaderShares Activist Leaders ETF
ACTV
-81,410
ADTN icon
3609
Adtran
ADTN
$741M
-10,887
AGGY icon
3610
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$874M
-44,528
AGO icon
3611
Assured Guaranty
AGO
$3.92B
-5,138
AHH
3612
Armada Hoffler Properties
AHH
$566M
-10,772
AMCX icon
3613
AMC Networks
AMCX
$360M
-11,141
AMRN
3614
Amarin Corp
AMRN
$307M
-1,330
ANY icon
3615
Sphere 3D
ANY
$10.5M
-10,002
APPF icon
3616
AppFolio
APPF
$7.83B
-3,029
AQST icon
3617
Aquestive Therapeutics
AQST
$404M
-26,316
ASPS icon
3618
Altisource Portfolio Solutions
ASPS
$62.7M
-9,500
ATOS icon
3619
Atossa Therapeutics
ATOS
$79.4M
-10,104
AVD icon
3620
American Vanguard Corp
AVD
$122M
-26,693
AVTR icon
3621
Avantor
AVTR
$8.29B
-15,187
SBLX
3622
StableX Technologies
SBLX
$4.63M
-1,250
BANR icon
3623
Banner Corp
BANR
$2.21B
-3,990
BASE
3624
DELISTED
Couchbase
BASE
-12,512
BEAM icon
3625
Beam Therapeutics
BEAM
$3.17B
-13,448